SPS Pharma Services relocates to a new facility
23 July 2013 | By SOTAX AG
SPS Pharma Services, a worldwide leader for dissolution method development has moved to its new site in Orleans, France...
List view / Grid view
News
“Roche Continents” at the Salzburg Festival explores the common ground of creativity in art and science
22 July 2013 | By Roche
Roche invites 100 students from all over Europe to the Salzburg Festival...
The Apprentice’s Nick Hewer to host IChemE Awards
22 July 2013 | By IChemE
The Institution of Chemical Engineers has announced The Apprentice’s Nick Hewer to host IChemE Awards...
US and EU regulatory authorities accept PLEGRIDY™ (peginterferon beta-1a) marketing applications for review
19 July 2013 | By Biogen Idec
U.S. and EU regulatory authorities have accepted marketing applications...
Roche launches new tests for monitoring transplant patients on immunosuppressive therapy
19 July 2013 | By Roche
Tests support long-term routine management of organ transplant recipients...
Roche launches new ProGRP test for more precise diagnosis in lung cancer
18 July 2013 | By Roche
Roche announced the global launch of Elecsys ProGRP...
Gilead announces interim Phase 2 data for idelalisib showing response in refractory indolent non-Hodgkin’s lymphoma
17 July 2013 | By Gilead Sciences
Results from Phase 2 study...
Boehringer Ingelheim and EFSD announce first recipients of diabetes research funding
17 July 2013 | By Boehringer Ingelheim
BI and EFSD commit €2.5 million to help accelerate European initiatives...
Novartis announces final agreement with Dr. Daniel Vasella
17 July 2013 | By Novartis
The Novartis Board of Directors announced a final agreement with its former Chairman, Dr. Daniel Vasella.
A 3D InSight™ into drug discovery with Tecan’s Infinite® M200 PRO
A novel solution for analyzing 3D cell cultures, based on Tecan’s Infinite® M200 PRO and InSphero’s 3D InSight™ microtissue technology, is helping to reduce the cost of early phase drug development.
The Lancet Oncology publishes results of XGEVA® (denosumab)
16 July 2013 | By Amgen
Phase 2 study reports safety and efficacy results in patients with giant cell tumor of bone...
GSK issue response to China investigation
16 July 2013 | By GSK
GSK issue a statement In response to the ongoing investigations by government authorities in China...
Approvals and launch update for XELJANZ® (tofacitinib citrate)
16 July 2013 | By Pfizer Inc.
Pfizer provides update on XELJANZ® (tofacitinib citrate) for the treatment of rheumatoid arthritis...
FDA approves Gilotrif™ (afatinib) as first-line treatment for lung cancer patients with EGFR mutations
16 July 2013 | By Boehringer Ingelheim
First approval for afatinib, the frontrunner from Boehringer Ingelheim’s new oncology pipeline...
Roche’s Erivedge receives conditional EU approval for treatment of advanced basal cell carcinoma
15 July 2013 | By Roche
The European Commission has granted conditional approval to Erivedge...
